AB
NAGE

Amalgamated Bank’s Niagen Bioscience NAGE Stock Holding History

Amalgamated Bank’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,663
Closed -$11K – 2933
2025
Q4 		$11K Sell
1,663
-31
-2% -$216 ﹤0.01% 2398
2025
Q3 		$16K Hold
1,694
– – ﹤0.01% 2252
2025
Q2 		$24K Hold
1,694
– – ﹤0.01% 2050
2025
Q1 		$12K Hold
1,694
– – ﹤0.01% 2302
2024
Q4 		$9K Hold
1,694
– – ﹤0.01% 2518
2024
Q3 		$6K Hold
1,694
– – ﹤0.01% 2733
2024
Q2 		$5K Buy
+1,694
New +$5.67K ﹤0.01% 2819
2022
Q2 		– Sell
-7,631
Closed -$19K – 3232
2022
Q1 		$19K Buy
+7,631
New +$20.9K ﹤0.01% 2825

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's NAGE Position: Q1 2026 in Review

Amalgamated Bank sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 1,663 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in NAGE in Q1 2022 and held it in 8 quarters. The position peaked at $24K in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

  • Amalgamated Bank reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,663 Niagen Bioscience shares in Q1 2026, an estimated $11K.
  • Amalgamated Bank first reported a position in Niagen Bioscience in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Niagen Bioscience position peaked at $24K in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.